Embecta Corp., a global medical supplies company with a 100-year legacy in insulin delivery, reported its second quarter fiscal 2026 financial results on May 5, 2026. The company also declared a quarterly cash dividend of $0.01 per share. Embecta continues to focus on expanding its medical supplies business and improving lives through innovative solutions. Investors can access the detailed earnings release and listen to the company's conference call for more insights.
A new patent application reveals a quantum AI project creating humanoid robots that can carry a person's 'digital DNA' to live alongside humans for centuries. This technology, part of a federally registered clinical trial, allows families to preserve...
The Rosen Law Firm is investigating potential securities claims against Putnam Investment Management, LLC, alleging the company may have provided misleading business information to investors in its stock-based mutual funds. Investors who purchased Pu...
CoreWeave secured a $35 billion deal with Meta, making Meta one of its largest customers through 2032. Despite this significant partnership, CoreWeave's shares fell following news related to Meta's own cloud services. The drop suggests investor conce...
Baker Hughes announced a quarterly cash dividend of $0.23 per Class A common share, payable on August 17, 2026, to shareholders recorded by August 7, 2026. The company plans to fund this dividend from operational cash flow. This dividend reflects Bak...
Morpho has experienced a notable increase in whale transactions, with 68 transfers over $100K in a single day, the highest since October 2025. This surge coincides with 337 new wallet creations, the largest growth since March 2026, indicating rising ...
